Changchun High-Tech unit's Gensci155 Injection clinical trial application approved by NMPA
Changchun High-Tech Industry Group Co Ltd said China's NMPA has approved a clinical trial application for its unit's Gensci155 Injection.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.